Pharmaceutical Recognition & Awards

The Corporate Presence can provide a range of commemorative designs, including those for FDA approvals, treatment studies, licensing, development, and commercialization agreements, and drug launches. We have unmatched expertise and experience in embedding drug vials.

Want to see what we can do for your organization?

Pharmaceutical Product Launch Commemorative

Lucite commemorative, incorporating a drug vial, celebrating the first product shipment by generic pharmaceutical company Civica.

(9AKL475)
1 Image

Drug Vial Embedment Celebrating FDA Approval

Custom Lucite with an embedded drug vial commemorating FDA approval of ELAHERE. Developed by ImmunoGen, the drug was granted accelerated FDA approval as a treatment for ovarian cancer. (23AKL266)

1 Image

FDA Approval Commemorative with Embedded Drug Vial

Custom Lucite, with an embedded drug vial, celebrating FDA approval of Cosela. (20ADH005)

1 Image

Merck Clinical Study Commemorative

Crystal commemorative recognizing team members in a first in-human clinical study of an anti-tumor therapy.

(9AJH024)
1 Image

New Drug Application Custom Crystal

Custom crystal celebrating the submission of a New Drug Application (NDA) to the Food and Drug Administration (FDA). The application, related to Impel NeuroPharma’s migraine treatment INP104, was supported by a Phase 3, open-label STOP-301 Trial.

(20ALJ356)
2 Images
Crystal commemorative marking the submission to the Food and Drug Administration (FDA) of a New Drug Application (NDA). INP104 was developed for the acute treatment of migraine headaches.

Tumor Treatment Licensing Agreement Commemorative

Crystal commemorative marking a licensing and commercialization agreement between Corbus Pharmaceuticals and CSPC Pharmaceutical Group. The agreement centers on a potential treatment for tumors associated with lung, breast, and prostate cancers. (23AZH089)

1 Image

Crystal Commemorative for Pharmaceutical Launch

Custom crystal commemorative celebrating the launch of Wynzora Cream, a topical treatment for plaque psoriasis that received approval from the FDA (Food and Drug Administration) in 2020. The product launch resulted from a collaboration agreement between Denmark-based MC2 Therapeutics, and EPI Health, a specialty pharmaceutical firm headquartered in Charleston, South Carolina.

(21ADH022)
1 Image

Custom Commemorative for Drug Licensing Agreement

Custom crystal commemorative, incorporating a periodic table theme, marking a licensing and commercialization agreement for a cancer drug developed by Rockville, Maryland-based biotech firm GlycoMimetics. The agreement applies to mainland China, Hong Kong, Taiwan, and Macau.

(20ALJ071)
1 Image

Ogsiveo FDA Approval Commemorative

Crystal commemorative celebrating FDA approval of Ogsiveo, a treatment for desmoid tumors. (24aZH051)

1 Image